The protein content of diphtheria-tetanus toxoids-acellular pertussis vaccines and an emerging clinical problem.
Cherry
James D
JD
D001315:Australia; D002170:Canada; D002648:Child; D004168:Diphtheria Toxoid / Q000032:analysis*; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry*; D005060:Europe; D006801:Humans; D007117:Immunization, Secondary; D014121:Toxoids / Q000032:analysis*; D014481:United States
D004168:Diphtheria Toxoid; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D014121:Toxoids; C051093:pertussis toxoid